TRIMETREXATE - PREDICTORS OF SEVERE OR LIFE-THREATENING TOXIC EFFECTS

被引：23

作者：

EISENHAUER, EA

ZEE, BC

PATER, JL

WALSH, WR

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1988年 / 80卷 / 16期

关键词：

D O I：

10.1093/jnci/80.16.1318

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1318 / 1322

页数：5

相关论文

共 12 条

[1]

BALIS FM, 1987, CANCER RES, V47, P4973

[2]

DIDDENS H, 1983, CANCER RES, V43, P5286

[3]

DONEHOWER RC, 1985, P AN M AM SOC CLIN, V4, P32

[4]

FANUCCHI MP, 1987, CANCER RES, V47, P3303

[5]

HEUSNER JJ, 1985, P AM ASSOC CANC RES, V26, P234

[6] CLINICAL-PHARMACOLOGY OF TRIMETREXATE [J].

HO, DHW ;

COVINGTON, WP ;

LEGHA, SS ;

NEWMAN, RA ;

KRAKOFF, IH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (03) :351-356

[7] UPTAKE AND EFFICACY OF TRIMETREXATE (TMQ, 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL] QUINAZOLINE), A NON-CLASSICAL ANTIFOLATE IN METHOTREXATE-RESISTANT LEUKEMIA-CELLS INVITRO [J].

KAMEN, BA ;

EIBL, B ;

CASHMORE, A ;

BERTINO, J .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (10) :1697-1699

[8]

MINI E, 1985, CANCER RES, V45, P325

[9]

ODWYER PJ, 1985, INVEST NEW DRUG, V3, P71

[10]

ODWYER PJ, 1987, NATL CANCER I MONOGR, V5, P105